31/01/08 Full Press Release (pdf) Full Press Release (HTML)
Novexin to Change Name to Expedeon Protein Solutions.
Novexin is delighted to announce that the company will be changing its name to Expedeon Protein Solutions. The name change reflects the company's renewed focus on providing simple, rapid and effective solutions for protein based research and production.
28/05/06
Novexin adds Industry Experts to its Board
Novexin, a company specialising in protein processing technology, is delighted to announce the appointment of Tim McCarthy and James Culverwell as non-executive directors. They will join founders Drs Trevor Jarman, Daniel Jones and Heikki Lanckriet on the Novexin Board.
Full press release (pdf)
04/04/06
Stabil-PAC, a New Protein Solubilising Kit Saves Valuable Time by Simplifying a Range of Protein Handling Processes
Cambridge, UK: Novexin, a company specialising in protein processing technology, is delighted to announce the availability of its new Stabil-PAC Kit, an affordable kit which helps improve protein solubility and stability to significantly increase productivity of protein purification, analysis and crystallisation processes.
Full press release (Word)
14/07/05
New range of protein refolding kits from Novexin offer a simple method of producing soluble yet active proteins
Novexin Ltd (“Novexin”) a company specialising in protein processing technology is pleased to introduce Refold Master, its innovative range of protein refolding kits. These generic laboratory scale kits, available directly from Novexin’s website (www.novexin.com), work with all proteins using just one set of conditions. This saves time and effort with screening and allows scientists that normally avoid working with insoluble proteins to progress their research with ease.
Full press release (Word)
01/07/05
75 times greater yield with Novexin technology
Novexin is pleased to announce that Belgian based VIB (Flanders Institute of Biotechnology), one of Europe's leading biotechnology institutes, is successfully using Novexin's refolding system to generate excellent yields of a previously insoluble IL15 protein.
Full press release (pdf)
28/09/04
Novexin gains £200,000 DTI award
Novexin has been awarded a £200,000 Grant for Research and Development by the Department of Trade and Industry (DTI) to develop further products for protein refolding. The company is delighted to receive this endorsement of its technology and predicted commercial importance.
Full press release (pdf)
09/02/04
Novexin acquires rights to new protein technology
Novexin announces that it has acquired technology to efficiently produce proteins from DNA through a novel protein refolding process. The technology is protected by two patents applications now acquired form the University of Cambridge.
Full press release (pdf)
05/01/04
Novexin welcomes Jon Goodall
Novexin is pleased to announce the recruitment of Dr Jon Goodall to the scientific development team. Jon holds a PhD in Biochemistry from the University of Birmingham and has previously worked for Roche and Basilea Pharmaceutica. Jon's skills in enzymology, protein chemistry and molecular biology will help Novexin to rapidly develop its proprietary protein refolding technology.
01/12/03
Novexin is expanding
Following successful progress in fundraising, Novexin wants to strengthen its scientific development team. If you hold a degree in biochemistry, molecular biology or a related discipline and have a PhD or equivalent post-graduate experience we might have the job you have been looking for.
10/11/03
Additional patent filed
Recently Novexin has filed a new patent application covering protein purification methods. Novexin believes it has now secured its platform technology for a wide variety of biotech applications. The company will now focus on the implementation of its innovating technology in consumer-friendly laboratory kits which will soon be available to the public.
15/10/03
Cambridge University Centre for Entrepreneurial Learning: "A recent success... Novexin"
The initial triggers for Novexin's rapid progress were the Centre for Entrepreneurial Learning's Basics of Building a Business course and assistance from the University of Cambridge Enterprise's Business Creation Team. As a product of Cambridge University’s endeavours to spin-out innovating and promising technology, Novexin recently featured on the Cambridge University Centre for Entrepreneurial Learning website.
01/10/03
Move to Babraham Bioincubator
On the first of October, Novexin moved to its new premises at the Babraham Bioincubator on the grounds of the Babraham Institute around six miles south of Cambridge. With a newly equipped laboratory in this stimulating environment, Novexin aspires to rapidly develop its products and technology
18/09/03
Presentation at GEIF
In light of its first fundraising Novexin presented its business ideas on protein refolding at the latest Great Eastern Investment Forum "presentation day" on the 18th of September 2003. Many investors took the opportunity to come and meet the dynamic Novexin team and discover all about Novexin’s exciting technology.
05/09/03
Novexin files patent
Novexin is proud to announce the filing of its first patent application. This patent application affords Novexin broad protection of its technology in the fields of protein refolding and protein processing.
15/09/03
Novexin wins Smart Award
Novexin has been successful in obtaining a prestigious Government Grant for Research and Development formerly known as "Smart Award".
The scheme is an initiative of the Department of Trade and Industry (DTI). It aims to help small businesses to research and develop innovative products and processes to provide a competitive edge to UK industry.
08/05/03
Novexin wins £10,000 in the Cambridge University Entrepreneurs Business Plan Competition
Six months of hard work have finally paid off. On Friday 8th May 2003, Novexin was announced as Runner-Up in the Cambridge University Entrepreneurs Business Plan Competition. The Novexin team was very pleased with this outcome and will use this prize money to help grow the company through its startup phase.
07/05/03
Presenting at ERBI
Novexin pitched its business plan and technology at the 6th edition of the Cambridge Biopartnering Exchange Event organised by Eastern Region Biotechnology Initiative (ERBI). Many leaders of well respected biotech companies such as Cambridge Antibodies and Alizyme were present at the event. The company received a good response from the well respected audience and hopes to build on the contacts it has made.
28/02/03
Incorporation
Today a new company is born. Novexin Ltd incorporated on the 28th of February 2003. It is a private UK based company founded by Daniel Jones and Heikki Lanckriet. The Company registration number is 4681599. Novexin Limited is the biotech company with an edge. Novexin has developed a new and fundamental platform technology that can solve a number of significant bioprocessing problems. Based on this innovative and proprietary technology the company will focus on obtaining rapid revenue generation through product sales.